L17E selectively directs its actions towards critical immune cells, thereby mitigating inflammation and impeding the progression of debilitating ailments. Through an array of exceptional preclinical investigations, L17E has exhibited remarkable outcomes and presents an unprecedented mechanism of action, instilling steadfast hope towards a paradigm shift in the realm of autoimmune disease management.
CAT# | GR2206 |
CAS | 2305578-13-4 |
M.F/Formula | C134H219N37O32S |
M.W/Mr. | 2860.41 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
C 21 is a kind of selective protein arginine methyltransferase 1 (PRMT1) inhibitor (IC50 = 1.8 μM). And it exhib ...
Basic Fibroblast Growth Factor, Human, called basic fibroblast growth factor (bFGF/FGF-b/FGF-2), is a single cha ...
PMX-53, a chemically synthesized peptide material, is a potent C5a antagonist in human neutrophils and macrophag ...
Delcasertib, also known as KAI-9803, is a 23-amino acid peptide and δ-protein kinase C (δ-PKC) inhibitor. KAI-9 ...
Deslorelin acetate, marketed under the trade names Ovuplant, SucroMate and Suprelorin, is an injectable gonadotr ...